May 28, 2020
Oncopeptides reinitiates patient enrollment to the melflufen clinical program following a temporary pause due to the COVID-19 pandemic
Media
May 27, 2020
BONESUPPORT has completed a directed share issue raising SEK 378 million
May 26, 2020
BONESUPPORT intends to carry out a directed share issue
May 26, 2020
Bulletin from the Annual General Meeting in Oncopeptides AB (publ)
May 26, 2020
Interim Report Q1 2020
May 26, 2020
Nordic Nanovector ASA: Results for the First Quarter 2020
May 22, 2020
Oncopeptides completes enrollment to the pivotal phase 3 study OCEAN for relapsed refractory multiple myeloma – 450 patients included
May 21, 2020
Carisma Therapeutics to Present and Meet with Potential Investors at Upcoming Healthcare Investor Conferences
May 20, 2020
Bulletin from the Annual General Meeting of Vicore Pharma Holding AB (publ)
May 20, 2020
Strongbridge Biopharma plc Announces $30 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
